Advertisement
Advertisement

HIV/AIDS NEWSROOM

CDC Explains and Defends Molecular Surveillance System

Not Surprisingly, PopART Study Showed Community-Based Services Reduce HIV Incidence

'Drug Users Are People Too': Addressing Opioid Addiction, Chemsex, Alcoholism, and Smoking Among People Living With HIV

This Week in HIV Research: Prevention and Treatment in the Real World

The Genetic Mutation Behind the Only Apparent Cure for HIV

Staying on PrEP is Significantly Different for People With Commercial Insurance Versus Medicaid

People With HIV Have Substantially Higher Risk of Sudden Cardiac Death at Low CD4 Counts or Detectable Viral Load

Drug Use May Be Increasing Syphilis Rates Among HIV-Positive Cisgender Women, Studies Show

New Option for PrEP: TAF/FTC Is Non-Inferior to TDF/FTC

TAF as Effective as TDF in Cisgender Women, With Fewer Side Effects

This Week in HIV Research: How Low (an Atripla Dose) Can You Go?

Phase 3 Results With Dual Therapy Cabotegravir/Rilpivirine Long-Acting Injections: ATLAS and FLAIR Studies

Viral Reservoir Can Explain Persistent Low Level Viremia With Good Adherence on ART

Dolutegravir More Effective Than Efavirenz at Achieving Viral Suppression During Late-Term Pregnancy, New Study Shows



Advertisement